Rapport Therapeutics develops precision neuromedicines that utilize Receptor Associate Proteins (RAPs) to target and regulate neuronal receptor complexes. Their lead program, RAP-219, focuses on treating focal epilepsy, while also exploring applications for neuropathic pain and bipolar disorder.
No jobs found. Subscribe below to get notified when we find something for you.
Searching
Companies
Want job alerts that match your preferences?
Set up job preferences →